- Pictorial Review
- Open Access
Orbital lymphoma: imaging features and differential diagnosis
Insights into Imaging volume 3, pages337–344(2012)
Patterns of orbital lymphoma at diagnosis and follow-up are described. We also discuss differential diagnosis of orbital masses.
Materials and methods
This pictorial review contains 19 cases of orbital lymphoma before and after treatment. Superior-lateral quadrant and extra-conal location were observed predominantly. Effective response after treatment was presented on follow-up imaging, although few local relapses were found. Further follow-up showed no changes of residual images.
Location of orbital masses can help in the differential diagnosis. Moreover, imaging features of lymphoma at diagnosis can be useful in planning surgical biopsy. Pattern of follow-up described may be relevant on monitoring imaging.
• Orbital lymphoma involves mainly superior-lateral quadrant and the orbital structures inside.
• Location of retrobulbar mass-like lesions are useful information in the differential diagnosis.
• Satisfactory response is detected after treatment, however relapse is noted, so follow-up is needed.
Orbital lymphoma represents a small fraction of all systemic lymphomas that account for approximately 1–2 % of non-Hodgkin lymphomas. Lymphoma is reported to constitute between 6 and 8 % of orbital tumours, however, the incidence is estimated to be rising and has doubled in the last two decades [1, 2].
Lymphoproliferative disease includes a spectrum of disorders ranging from benign (lymphoid hyperplasia) to malignant disease (lymphoma), passing by atypical lymphoid hyperplasia. Immunohistochemical and molecular biological studies have been reliable to differentiate these entities. Orbital lymphomas are a heterogeneous group of malignancies, most of them are primary extranodal lymphoma of the marginal zone of mucosa associated with lymphoid tissue (MALT type lymphoma). These lymphomas arise in lymphoid tissue acquired in certain extranodal sites as a result of chronic inflammation or autoimmune disorders. Recent advances in molecular and cytogenetics establish that lymphoma can be associated with Chlamydia psittaci infection .
This tumour is seen more commonly in the 5th–7th decades of life with a slight female predominance. The orbital infiltration by lymphoma is characterised by a palpable, firm or rubbery mass. Other symptoms are progressive proptosis, decreased visual acuity, motility disturbances and diplopia. Occasionally, periorbital oedema is seen [4–6].
The radiological findings found in orbital lymphoma have been previously reported in the literature. This tumour has been described as a mass with distinct margins, which shows an isointense signal on T1-weighted images and iso-hyperintense on T2-weighted images. Variable enhancement has been reported after contrast administration . Previous published reports display useful information that can help to differentiate orbital lymphoma from other masses. Spiral computed tomography (CT) using a dual-phase contrast-enhancement protocol report that lymphomas have a decrease in density on delayed images, as opposed to orbital pseudotumours, whose density increases on delayed images . Moreover, low values in the apparent diffusion coefficient on diffusion-weighted magnetic resonance imaging (MRI) have been found helpful to discriminate lymphoma from other expansive orbital lesions .
This review is focused on describing the patterns of orbital lymphoma. The characteristic distribution and infiltration of some orbital structures will define useful items to orientate a proper diagnosis. Additionally, this information can be helpful in ophthalmological surgery to obtain an optimal sample for accurate diagnosis. Differential diagnosis regarding the location of orbital masses will be developed in this article. Moreover, the patterns during follow-up and the frequency of relapses are described. This information will assist the radiologist for proper monitoring.
Materials and methods
Inclusion criteria in this retrospective study were: (1) histological confirmation of lymphoma by biopsy and (2) to have available radiological exams before and after treatment. Nineteen patients (11 men and eight women, age range 37–80 years, mean 60) fulfilled the inclusion criteria and were included in the study. Fifteen cases were examined by CT and four by MRI.
Imaging of the orbit was performed by CT with the following technique: voltage: 120 kV, current: 150 mA, rotation time: 0.65 s, dose profile average: DLP: 175 mGy·cm and CTDIvol: 20 mGy and/or a 1.5-T MRI system. Axial acquisition and coronal reconstruction without and with contrast was done on CT scans. The MRI protocol included: axial and coronal T2-weighted imaging and T1 without and with contrast, and fat suppression T1-weighted imaging after contrast.
Informed consent for clinical radiological exams were obtained for all patients included in this retrospective research. Most lymphomas included in the study were MALT category, other histological subtypes found were as shown in Table 1.
In order to make a proper description of the tumour, the orbit was divided into four separated quadrants. Taking into account this classification, number of involved quadrants (1/2/3/4) and dominant quadrant (superior-lateral/superior-medial/inferior-lateral/inferior-medial) were evaluated in our study. Moreover, the following radiological data were analysed as well: bilaterality (unilateral/bilateral), distribution (intra-conal/extra-conal/intra- or extra-conal) and orbital structures affected (conal muscles, lacrimal gland, eyelid and optic nerve).
Ann Arbor classification was followed in our centre, thus, stage I (single orbit extralymphatic site) and low-grade tumours were treated by radiotherapy (overall dose of 35–40 Gy, in fractions of 2 Gy) for 1 month. Otherwise, aggressive subtype lymphoma or advanced stage (II, III or IV of Ann Arbor Criteria) combined with chemotherapy . Radiological findings were reviewed regarding treatment response related to the size of orbital tumour during the follow-up. The following degrees of response were considered in the first check-up (after 6-12 months): complete response (disappearance of lesion), partial response (decrease of the size of the tumour of more than 50 % of the longest diameter), stable disease (decrease of less than 50 % or increase of less than 25 %) and progressive disease (increase of more than 25 %). Further follow-up exams were reviewed in some patients at time intervals of 1 year on average.
The results are divided into the following items: patterns of involvement at diagnosis, follow-up and relapses.
Regarding the number of affected quadrants, one quadrant was the main form (12/19, 63 %). Involvement of two (5/19, 26 %) and three quadrants (2/19, 11 %) were uncommon.
The most frequent location was the superior-lateral quadrant (11/19, 59 %). The superior-medial quadrant was involved secondary (5/19, 26 %). Inferior quadrants were unusual (3/19, 15 %) (Fig. 1a).
Most cases had unilateral involvement (18/19, 95 %) whereas bilateral affectation was exceptional (1/19, 5 %) (Fig. 1b).
Based on the classical division of the orbit, the following spaces were considered: extra-conal compartment (outside the muscles cone) and intra-conal compartment (inside the muscles cone). Depending on this classification, the distribution of orbital lymphoma cases in order of frequency was: intra- and extra-conal (9/19, 47 %), extra-conal (8/19, 42 %) and intra-conal (2/19, 11 %).
Regarding the orbital structures involved by lymphoma, the following results were found in descending order: superior rectus muscle (14/19, 74 %), lateral rectus muscle (11/19, 59 %), eyelid (10/19, 53 %) and lacrimal gland (9/19, 47 %). Some examples of these localisations are shown in Fig. 2. The remaining conal muscles were less frequently affected. Contact with optic nerve was reported in two cases.
Other locations were described exceptionally in the literature, such as intracranial dural extension, which were not found in our study . No tumoural calcification was observed in this review, nor involvement of bony structures. Although lymphoma can contact with bony orbital structures, no erosion or hyperostosis was noted. Similar behaviour within the eyeball has been described. Wide contact and even displacement of the globe have been observed, although no intraocular mass or infiltration signs were reported. Despite these features being observed in our images, radio-pathological correlation was not performed.
In addition, localisation of lymphoma is useful information when planning the appropriate surgical technique. For example, the management of adjacent structures, such as conal muscles, feeding vessels and nerves should determined. This information is helpful in order to avoid surgical complications.
The assessment at first post-treatment follow-up exam was tabulated as follows: complete response (3/19, 15 %) (Fig. 3) and partial response (15/19, 80 %) (Fig. 4). Progressive imaging disease was observed in 1/19, 5 %, although satisfactory clinical response was seen before.
Further follow-up exams were performed every 12 months on average within a period from 1 to 5 years (mean, 2 years). Most subjects showed no changes, or even decreased size, of the residual images. However, relapses have been reported in two patients after 1 and 3 years, respectively (Fig. 5).
In this study, we have found that lymphomas have a characteristic localisation in the orbit that can assist radiologists to orientate a proper diagnosis. This typical location consists of the involvement of superior quadrants; specifically, the superior-lateral one. The most commonly infiltrated structures are found within the superior-lateral quadrant, such as the superior rectus muscle, lateral rectus muscle, lacrimal gland and eyelid. Involvement of intra-conal space is usually associated with the extra-conal one, and is related with large size of the tumour. Therefore, an intra-conal involvement alone will not be the main pattern of lymphoma in the orbit. In addition, low prevalence is described within occupation of lower quadrants and contact with the optic nerve.
These conclusions may help in the differential diagnosis of retrobulbar orbital mass-like lesions in adults. No globe tumours or childhood diseases are included. Classical distribution of intra/extra-conal spaces are used in the differential diagnosis as shown in Fig. 6 [11, 12]:
The most common intra-conal tumours are meningioma and glioma (Fig. 7). Optic nerve sheath meningioma is a solid, tubular, well-defined mass which presents uniform intense enhancement after contrast compared with the non-enhancing optic nerve (“tram-track sign” on axial images and “bull’s eye” on coronal images) [13, 14]. Around a third to a half display calcifications. Due to the characteristic encasement of meningioma it entails the well-known “perioptic cyst” between tumour and globe. Optic nerve glioma is frequently an aggressive subtype in adults. There is unilateral enlargement, moderate irregular enhancement and posterior extension. Bilateral low grade glioma associated with NF occurs most often in paediatric patients [15, 16].
Cavernous haemangioma (or malformation) is commonly found as a well-defined intra-conal mass bounded by a fibrous pseudocapsule which manifests proptosis. High density can be identified due to microcalcification and may have low-intensity septation on T2-weighted imaging. Dynamic enhancement started from one point or portion and fills homogeneously on delayed images [17–20]. Another exceptional retrobulbar mass lesion might include Erdheim-Chester disease, which presents bilateral intra-conal masses associated with skeletal, retroperitoneal and pulmonary manifestations [21, 22].
The differential diagnosis for masses involving the intra- and extra-conal compartment should include (Fig. 8): inflammatory/metabolic disease (orbital inflammatory pseudotumour, thyroid orbitopathy, sarcoidosis) and neoplasm (lacrimal tumours, lymphoma and metastasis). Exceptional diseases—such as Sjögren, Wegener, and Kimura diseases—are just mentioned. Cystic retrobulbar lesions (such as dermoid and epidermoid cyst or mucocele) have different density (on CT) and intensity (on MRI) from soft tissue mass.
Lymphoproliferative disease of the orbit is a spectrum of disorders that are included in this differential. All three entities mentioned before (lymphoid hyperplasia, atypical hyperplasia and lymphoma) are challenging to differentiate by imaging, however, hyperplasia occupies mainly intra-conal space .
Inflammatory pseudotumours are often associated with fat tissue infiltration or oedema. Hypointense T2 signal is a helpful feature in order to differentiate from other tumours . Extraorbital extension has been reported . Variable contrast enhancement is described, although dual-phase contrasted CT reported an increased density on delayed images .
Thyroid orbitopathy consist in thickened muscles bellies over 4 mm. Common rectus muscles involved are inferior, medial, superior and lateral (mnemotecnics: “I’M SLow”). The tendinous insertion is usually not involved. Prominent intra-conal fat can also result in proptosis.
Sarcoidosis is a non-caseating granulomatous inflammation. Diffuse infiltration of orbital structures and dural thickening is identified [25, 26]. Finally, any malignant tumour may metastasise within the orbit. Characteristic finding may be hyperintensity on T2-weighted imaging and heterogeneous enhancing mass. Bone destruction can occur [27, 28].
Lacrimal gland lesions can be classified into epithelial and non-epithelial. Epithelial tumours can be benign (pleomorphic adenoma) or malignant (pleomorphic adenocarcinoma). Carcinomas have heterogeneous signal intensity on T1- and T2-weighted images. Scalloped remodelling of bone structures and punctate calcification are occasionally identified .
Radiological pattern after treatment can be helpful to the radiologist in monitored reports. Accordingly, 95 % of cases showed satisfactory response at first check post-treatment. Residual images were stable in most of the cases at the further follow-up. Previous studies [29–31] have also described some evidence of the high sensitivity of orbital to radiation therapy.
Although outstanding results have been achieved with radiotherapy, a balance against frequent treatment-related toxicities is needed. The most common toxicities consist of cutaneous and conjunctival reactions. Other long-term complications are cataract formation and xerophthalmia. High radiation dose may result in severe ophthalmological toxicity, such as ischaemic retinopathy, optic atrophy, corneal ulceration and neovascular glaucoma, associated with significant vision loss . Therefore, although the recommended treatment is radiotherapy, there is no consensus on the optimal dose to be administered. New guidelines like the National Cancer Centre Network support low dose of radiotherapy at an early stage. Additional radiotherapy could be offered in recurrences . Hence, these trends imply a relevant role of the radiological follow-up. The radiological evaluation should be as accurate as possible in order to detect orbital recurrences of lymphoma at an early stage. On the other hand, the radiation dose is essential information in monitoring.
This study provides a pattern of localisation of lymphoma which will be valuable for radiologists in the differential diagnosis of orbital masses. Combined CT and MRI can orientate a proper orbital mass diagnosis, although biopsy will still be required, imaging can help in this process too. It also offers a post-treatment guide of response after treatment which could be certainly beneficial in daily radiological practice. Some limitations should be considered in this study. First, most of our cases were evaluated by CT-scanning alone, with MRI being used in a low percentage of cases. We consider that multiplanar reconstruction and thin slice thickness by CT allows a correct localisation of lymphoma in orbit. Besides, intra-orbital fat provides natural contrast in CT exams, which achieves satisfactory differentiation of other structures. Furthermore, calcifications can be useful in the differential as well as the involvement of bony structures. Despite CT and MRI having a complementary role in the assessment of mass-like lesions in the orbit, MRI provides higher resolution in soft tissue evaluation. Moreover, recent development techniques such as marked thin slices and diffusion have an important value in the diagnosis and monitoring of lymphoma . Due to this recent evidence and in order to avoid irradiation of the orbit, MRI will be the modality of choice, even if both techniques are available. Second, this is a retrospective study with a heterogeneous range of techniques used and periods of follow-up. Nevertheless, several cases and follow-up times were found, despite the low frequency of this disease, providing useful knowledge about this quite uncommon entity. Future research can be focused in the quadrants involved by the diverse orbital masses as well as the post-treatment monitoring depending on the dose of radiotherapy in lymphoma.
Bardenstein D (2005) Ocular adnexal lymphoma: classification, clinical disease, and molecular biology. Ophthalmol Clin North 18:187–197
Sjo LD, Ralfkiaer E, Prause JU, Petersen JH, Madsen J, Pedersen NT, Heegaard S (2008) Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283–3288
McKelvie PA (2010) Ocular adnexal lymphomas: a review. Adv Anat Pathol 17:251–261
Gordon PS, Juillard JF, Seich M, Parker G, Fu YS (1986) Orbital lymphomas and pseudolymphomas: treatment with radiation therapy. Radiology 159:797–799
Rey-Porca C, Pérez-Encinas M, González F (2008) Orbital lymphomas: presentation of nine cases. Arch Soc Esp Oftalmol 83:95–103
Meunier J, Lumbroso L, Vincent-Salomon A, Dendale R, Asselain B, Arnaud P, Fourquet A, Desjardins L, Plancher C, Validire P, Chaoui D, Lévy C, Decaudin D (2004) Ophthalmologic and intraocular non-Hodgkin’s lymphoma: a large single centre study of initial characteristics, natural history and prognostic factors. Hematol Oncol 22:143–158
Akansel G, Hendrix L, Erickson BA, Demirci A, Papke A, Arslan A, Ciftci E (2005) MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates. Eur J Radiol 53:175–181
Moon WJ, Na DG, Ryoo JW, Kim MJ, Kim YD, Lim DH, Byun HS (2003) Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 27:510–516
Politi LS, Forghani R, Godi C, Resti AG, Ponzoni M, Bianchi S, Iadanza A, Ambrosi A, Falini A, Ferreri AJ, Curtin HD, Scotti G (2010) Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574
Cohen V (2009) Treatment options for ocular adnexal lymphoma. Clin Ophthalmol 3:689–692
Lemke AJ, Kazi I, Felix R (2006) Magnetic resonance imaging of orbital tumors. Eur Radiol 16:2207–2219
Xian J, Zhang Z, Wang Z, Li J, Yang B, Man F, Chang Q, Zhang Y (2010) Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol 20:1692–1702
Kanamalla US (2003) The optic nerve tram-track sign. Radiology 227:718–719
Becker M, Masterson K, Delavelle J, Viallon M, Vargas MI, Becker CD (2010) Imaging of the optic nerve. Eur J Radiol 74:299–313
Millar WS, Tartaglino LM, Sergott RC, Friedman DP, Flanders AE (1995) MR of Malignant Optic Glioma of Adulthood. AJNR Am J Neuroradiol 16:1673–1676
Chung EM, Specht CS, Schoeder JW (2007) Pediatric orbit tumors and tumorlike lesions: neuroepithelial lesions of the ocular globe and optic nerve. Radiographics 27:1159–1186
Wilms G, Raat H, Dom R, Thywissen C, Demaerel P, Dralands G, Baert AL (1995) Orbital cavernous hemangioma: findings on sequential Gd-enhanced MRI. J Comput Assist Tomogr 19:548–551
Thorn-Kany M, Arrué DMB, Lacroix F, Lagarrigue J, Manelfe C (1999) Cavernous hemangiomas of the orbit MR imaging. J Neuroradiol 26:79–86
Tanaka A, Mihara F, Yoshiura T, Togao O, Kuwabara Y, Natori Y, Sasaki T, Honda H (2004) Differentiation of cavernous hemangioma from Schwannoma of the orbit: a dynamic MRI study. AJR Am J Roentgenol 183:1799–1804
Smoker W, Gentry L, Yee N, Reede D, Nerad J (2008) Vascular lesions of the orbit: more than meets the eye. Radiographics 28:185–204
Adem C, Helie O, Leveque C, Taillia H, Cordoliani YS (2005) Case 78: Erdheim-Chester disease with central nervous system involvement. Radiology 234:111–115
Johnson MD, Aulino JP, Jagasia M, Mawn LA (2004) Case report Erdheim-Chester disease mimicking multiple meningiomas síndrome. AJNR Am J Neuroradiol 25:134–137
Narla LD, Newman B, Spottswood S, Narla S, Kolli R (2003) Inflammatory pseudotumor. Radiographics 23:719–729
Lee EJ, Jung SJ, Kim BS, Ahn KJ, Kim YJ, Jung AK, Park CS, Song SY, Park NH, Kim SM (2005) MR imaging of orbital inflammatory pseudotumors with extraorbital extension. Korean J Radiol 6:82–88
Simon EM, Zoarski GH, Rothman MI, Numaguchi Y, Zagardo MT, Mathis JM (1998) Systemic sarcoidosis with bilateral orbital involvement: MR findings. AJNR Am J Neuroradiol 19:336–337
Mafee MF, Dorodi S, Pai E (1999) Sarcoidosis of the eye, orbit and central nervous system. Radiol Clin North Am 37:73–87
Gotwald TF, Zinreich SJ, Schocke M, Frede T, Bellmann R, Nedden Z (2000) CT and MR imaging of orbital metastasis from islet cell carcinoma of the pancreas. AJR Am J Roentgenol 175:475–476
Char DH, Miller T, Kroll S (1997) Orbital metastases: diagnosis and course. Br J Ophthalmol 81:386–390
Decaudin D, Cremoux P, Vincent-Salomon A, Dendale R, Lumbroso L (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451–1460
Bayraktar S, Bayraktar U, Stefanovic A, Lossos IS (2011) Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol 152:72–80
Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ (2003) Localized mucosa associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 22:4157–4164
Singh AD (2007) Clinical ophthalmic oncology. In: Damato BE, Pe’er J, Murphree AL, Perry JD (eds) Orbital and adnexal lymphoma (Orbital tumors). Elsevier, Philadephia, pp 565–570
Stefanovic A, Lossos I (2009) Extranodal marginal zone lymphoma of the ocular adnexa. Blood 114:501–510
About this article
Cite this article
Priego, G., Majos, C., Climent, F. et al. Orbital lymphoma: imaging features and differential diagnosis. Insights Imaging 3, 337–344 (2012). https://doi.org/10.1007/s13244-012-0156-1
- Orbital adnexa
- Magnetic resonance imaging
- Computed tomography